Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial
PaperCitations, authors & open-access status
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 332 citations, 2016 year and closed oa status.
332
Citations
2016
Year
closed
OA Status